Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
InnoCare Pharma's Orelabrutinib Shows Efficacy in RRMS at ACTRIMS Forum
CompanyDrug

InnoCare Pharma’s Orelabrutinib Shows Efficacy in RRMS at ACTRIMS Forum

February 27, 2025
Jiangsu Hengrui's HRS-1301 Receives NMPA Approval for Hyperlipidemia
CompanyDrug

Jiangsu Hengrui’s HRS-1301 Receives NMPA Approval for Hyperlipidemia

February 27, 2025
Hepalink Pharmaceutical's Enoparin Receives Argentina Approval for Thromboembolic Diseases
CompanyDrug

Hepalink Pharmaceutical’s Enoparin Receives Argentina Approval for Thromboembolic Diseases

February 27, 2025
Bio-heart's Iberis System Approved by NMPA for Hypertension Treatment
CompanyMedical Device

Bio-heart’s Iberis System Approved by NMPA for Hypertension Treatment

February 27, 2025
Fosun Pharma's Tenapanor Approved in China for CKD Dialysis Patients
CompanyDrug

Fosun Pharma’s Tenapanor Approved in China for CKD Dialysis Patients

February 27, 2025
WuXi XDC Expands MOU with LigaChem to Advance Next-Gen ADC Development
CompanyDeals

WuXi XDC Expands MOU with LigaChem to Advance Next-Gen ADC Development

February 26, 2025
Kexing Biopharm and Bio-Sincerity Pharmaceutical Form Strategic Alliance
CompanyDeals

Kexing Biopharm and Bio-Sincerity Pharmaceutical Form Strategic Alliance

February 26, 2025
Harbour BioMed Licenses HAT001/HBM9013 to Global Partner for CRH-Targeted Therapy
CompanyDeals

Harbour BioMed Licenses HAT001/HBM9013 to Global Partner for CRH-Targeted Therapy

February 26, 2025
Basecare and Rhea Labs Form Five-Year Alliance to Expand IVF Markets Globally
CompanyDeals

Basecare and Rhea Labs Form Five-Year Alliance to Expand IVF Markets Globally

February 26, 2025
Takeda Partners with BridGene to Develop Immunology and Neurology Drug Candidates
CompanyDeals

Takeda Partners with BridGene to Develop Immunology and Neurology Drug Candidates

February 26, 2025
Hansoh Pharmaceutical's HS-10561 Receives NMPA Clearance for Chronic Spontaneous Urticaria
CompanyDeals

Hansoh Pharmaceutical’s HS-10561 Receives NMPA Clearance for Chronic Spontaneous Urticaria

February 26, 2025
J&J MedTech Launches Locally Produced HARMONIC 7s Scalpel in China
CompanyMedical Device

J&J MedTech Launches Locally Produced HARMONIC 7s Scalpel in China

February 26, 2025
1 2 3 4 5 … 26 27
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up